Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection

Item

http://www.wikidata.org/entity/Q38632038

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Nonnucleoside reverse transcri ...... ring early stages of infection

@en

type

Item

label

Nonnucleoside reverse transcri ...... ring early stages of infection

@en

prefLabel

Nonnucleoside reverse transcri ...... ring early stages of infection

@en

P1476

Nonnucleoside reverse transcri ...... ring early stages of infection

@en

P2093

Carrie Dykes

http://www.w3.org/2001/XMLSchema#string

Dongge Li

http://www.w3.org/2001/XMLSchema#string

Gang Zhang

http://www.w3.org/2001/XMLSchema#string

Hannah M Smith

http://www.w3.org/2001/XMLSchema#string

Hua Liang

http://www.w3.org/2001/XMLSchema#string

Hulin Wu

http://www.w3.org/2001/XMLSchema#string

Jiong Wang

http://www.w3.org/2001/XMLSchema#string

Lisa M Demeter

http://www.w3.org/2001/XMLSchema#string

Nicholas R Lowe

http://www.w3.org/2001/XMLSchema#string

Robert A Bambara

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research

Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol

Human immunodeficiency virus reverse transcriptase and protease sequence database

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine.

P304

10861-10873

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.05116-11

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51565855

http://www.w3.org/2001/XMLSchema#string

P698

21835788

http://www.w3.org/2001/XMLSchema#string

P932

3187512

http://www.w3.org/2001/XMLSchema#string